indication
as of 2026-07-01Smoking Cessation
Competitive landscape projected to varenicline (CP-526,555)’s launch window
Competitive set
1
1 approved · 0 pipeline
Projection timeline
actual past → guided future · protection walls overlaid
18 events
2020
2024
2028
2032
2036
2040
today
varenicline (CP-526,555) launch window
guided / estimated ↑
actual ↓
focal / guidedapprovallabel expansiontrial readoutcongressnclustered events (click to expand)guided (dashed = directional)competitor patent cliff
Competitive set
resolved drugs with trials in this indicationdrugCompleted
US-approved 1993 · RISPERDAL
Phase 31 trial
Protection2042
Market size
prevalence as a range, not a number